Bios Equity Partners reported a 7.4% stake in Lantern Pharma LTRN · 834,752 sh · amendment

Trade details

Type: 5% stake report
Report: 13D · amendment
Stake: 7.4%
Last report: 8.58% · filed 26/02/23
Shares held: 834,752 sh
Class: Common Stock, par value $0.0001 per share
Stock: Lantern Pharma LTRN
Holder: Bios Equity Partners
Event date: 26/04/16
Filed: 26/04/16

7.4% stake · −1.2pp from the last report

Stake: 7.4%
Last report: 8.58%
Since last report: −1.2pp

Lantern Pharma trades, last 26 weeks

What else happened in Lantern Pharma around then

Filed or reported within 30 days of the trade day · 03/17~05/16

Bios Equity Partners's other 5% stake reports

Bios Equity Partners
5% stakeLantern Pharma
5% stake
Lantern Pharma
LTRN
4.48% stake
571,305 sh
4.48% stake
Filed 05/15
Bios Equity Partners
5% stakeLantern Pharma
5% stake
Lantern Pharma
LTRN
8.58% stake
960,026 sh
8.58% stake
Filed 02/23
Bios Equity Partners
5% stakeLantern Pharma
5% stake
Lantern Pharma
LTRN
9.98% stake
1,075,952 sh
9.98% stake
Filed 25/06/13